JP2019500048A - ペットフード組成物 - Google Patents
ペットフード組成物 Download PDFInfo
- Publication number
- JP2019500048A JP2019500048A JP2018534734A JP2018534734A JP2019500048A JP 2019500048 A JP2019500048 A JP 2019500048A JP 2018534734 A JP2018534734 A JP 2018534734A JP 2018534734 A JP2018534734 A JP 2018534734A JP 2019500048 A JP2019500048 A JP 2019500048A
- Authority
- JP
- Japan
- Prior art keywords
- pet food
- source
- food composition
- polyphenol
- fiber source
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 99
- 235000013305 food Nutrition 0.000 title claims abstract description 54
- 239000000835 fiber Substances 0.000 claims abstract description 73
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 57
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 57
- 241000124008 Mammalia Species 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 23
- 239000000758 substrate Substances 0.000 claims abstract description 22
- 238000013270 controlled release Methods 0.000 claims abstract description 19
- 210000001035 gastrointestinal tract Anatomy 0.000 claims abstract description 10
- 230000037406 food intake Effects 0.000 claims abstract description 6
- 241001465754 Metazoa Species 0.000 claims description 21
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 16
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 10
- 239000011248 coating agent Substances 0.000 claims description 8
- 238000000576 coating method Methods 0.000 claims description 8
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims description 7
- 244000005709 gut microbiome Species 0.000 claims description 6
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 5
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 5
- 235000021323 fish oil Nutrition 0.000 claims description 5
- -1 iupafolin Chemical compound 0.000 claims description 5
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 claims description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims description 4
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 claims description 4
- 235000012054 meals Nutrition 0.000 claims description 4
- 208000024891 symptom Diseases 0.000 claims description 4
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 3
- 241000335053 Beta vulgaris Species 0.000 claims description 3
- 244000068645 Carya illinoensis Species 0.000 claims description 3
- 235000009025 Carya illinoensis Nutrition 0.000 claims description 3
- 241000287828 Gallus gallus Species 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 208000035475 disorder Diseases 0.000 claims description 3
- 208000027866 inflammatory disease Diseases 0.000 claims description 3
- 210000004185 liver Anatomy 0.000 claims description 3
- DMXHXBGUNHLMQO-UHFFFAOYSA-N pedaliin Natural products C1=C2OC(C=3C=C(O)C(O)=CC=3)=CC(=O)C2=C(O)C(OC)=C1OC1OC(CO)C(O)C(O)C1O DMXHXBGUNHLMQO-UHFFFAOYSA-N 0.000 claims description 3
- 150000007965 phenolic acids Chemical class 0.000 claims description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 claims description 2
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims description 2
- XUSYGBPHQBWGAD-PJSUUKDQSA-N Carnosol Chemical compound CC([C@@H]1C2)(C)CCC[C@@]11C(=O)O[C@@H]2C2=C1C(O)=C(O)C(C(C)C)=C2 XUSYGBPHQBWGAD-PJSUUKDQSA-N 0.000 claims description 2
- MMFRMKXYTWBMOM-UHFFFAOYSA-N Carnosol Natural products CCc1cc2C3CC4C(C)(C)CCCC4(C(=O)O3)c2c(O)c1O MMFRMKXYTWBMOM-UHFFFAOYSA-N 0.000 claims description 2
- 241000207199 Citrus Species 0.000 claims description 2
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 claims description 2
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 2
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 2
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 claims description 2
- 240000005979 Hordeum vulgare Species 0.000 claims description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 2
- DMXHXBGUNHLMQO-IWLDQSELSA-N Nepitrin Chemical compound C1=C2OC(C=3C=C(O)C(O)=CC=3)=CC(=O)C2=C(O)C(OC)=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DMXHXBGUNHLMQO-IWLDQSELSA-N 0.000 claims description 2
- SGOMZDKEAPBAGC-UHFFFAOYSA-N Nepitrin Natural products COC1C(O)C(O)C(Oc2cc3OC(=CC(=O)c3c(O)c2OC)c4ccc(O)c(O)c4)OC1CO SGOMZDKEAPBAGC-UHFFFAOYSA-N 0.000 claims description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims description 2
- CEEMRWKKNNEQDT-UHFFFAOYSA-N Rosmanol Natural products CC(C)c1cc2C(OC(=O)C)C3OC(=O)C4(CCCC(C)(C)C34)c2c(OC(=O)C)c1OC(=O)C CEEMRWKKNNEQDT-UHFFFAOYSA-N 0.000 claims description 2
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 claims description 2
- 240000003768 Solanum lycopersicum Species 0.000 claims description 2
- DJSISFGPUUYILV-UHFFFAOYSA-N UNPD161792 Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 claims description 2
- 235000004654 carnosol Nutrition 0.000 claims description 2
- NPLTVGMLNDMOQE-UHFFFAOYSA-N carthamidin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=C(O)C(O)=C2C(=O)C1 NPLTVGMLNDMOQE-UHFFFAOYSA-N 0.000 claims description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000005487 catechin Nutrition 0.000 claims description 2
- 229950001002 cianidanol Drugs 0.000 claims description 2
- 235000020971 citrus fruits Nutrition 0.000 claims description 2
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 claims description 2
- 235000007336 cyanidin Nutrition 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 229930003935 flavonoid Natural products 0.000 claims description 2
- 150000002215 flavonoids Chemical class 0.000 claims description 2
- 235000017173 flavonoids Nutrition 0.000 claims description 2
- 229940025878 hesperidin Drugs 0.000 claims description 2
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 claims description 2
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 claims description 2
- 235000008777 kaempferol Nutrition 0.000 claims description 2
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 claims description 2
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 claims description 2
- 235000009498 luteolin Nutrition 0.000 claims description 2
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 claims description 2
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 claims description 2
- 229940038580 oat bran Drugs 0.000 claims description 2
- 235000005875 quercetin Nutrition 0.000 claims description 2
- 229960001285 quercetin Drugs 0.000 claims description 2
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 claims description 2
- LCAZOMIGFDQMNC-FORWCCJISA-N rosmanol Chemical compound C1CCC(C)(C)[C@@H]2[C@H]3[C@@H](O)C(C=C(C(=C4O)O)C(C)C)=C4[C@]21C(=O)O3 LCAZOMIGFDQMNC-FORWCCJISA-N 0.000 claims description 2
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 claims description 2
- DJSISFGPUUYILV-ZFORQUDYSA-N scutellarin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-ZFORQUDYSA-N 0.000 claims description 2
- 229930190376 scutellarin Natural products 0.000 claims description 2
- 235000013311 vegetables Nutrition 0.000 claims description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 28
- 235000005911 diet Nutrition 0.000 description 21
- 239000003795 chemical substances by application Substances 0.000 description 19
- 230000009286 beneficial effect Effects 0.000 description 17
- 230000037213 diet Effects 0.000 description 14
- 210000002966 serum Anatomy 0.000 description 14
- 239000002207 metabolite Substances 0.000 description 12
- 230000000813 microbial effect Effects 0.000 description 10
- 235000021195 test diet Nutrition 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000001072 colon Anatomy 0.000 description 8
- 235000020940 control diet Nutrition 0.000 description 8
- 235000016709 nutrition Nutrition 0.000 description 8
- 230000000378 dietary effect Effects 0.000 description 7
- 238000004090 dissolution Methods 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 102000004127 Cytokines Human genes 0.000 description 5
- 108090000695 Cytokines Proteins 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000002550 fecal effect Effects 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 210000003651 basophil Anatomy 0.000 description 3
- 238000010201 enrichment analysis Methods 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 101710155857 C-C motif chemokine 2 Proteins 0.000 description 2
- 102000000018 Chemokine CCL2 Human genes 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- 229920003155 Eudragit® RL 100 Polymers 0.000 description 2
- 229920003159 Eudragit® RS 100 Polymers 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 102000003814 Interleukin-10 Human genes 0.000 description 2
- 108090000174 Interleukin-10 Proteins 0.000 description 2
- 102000013462 Interleukin-12 Human genes 0.000 description 2
- 108010065805 Interleukin-12 Proteins 0.000 description 2
- 102000004889 Interleukin-6 Human genes 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- 108010025020 Nerve Growth Factor Proteins 0.000 description 2
- 102000015336 Nerve Growth Factor Human genes 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 239000012867 bioactive agent Substances 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000001055 chewing effect Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000016396 cytokine production Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 229960004956 glycerylphosphorylcholine Drugs 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 229940100601 interleukin-6 Drugs 0.000 description 2
- 230000007413 intestinal health Effects 0.000 description 2
- 210000003750 lower gastrointestinal tract Anatomy 0.000 description 2
- 235000021073 macronutrients Nutrition 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000002705 metabolomic analysis Methods 0.000 description 2
- 230000001431 metabolomic effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- FHHSEFRSDKWJKJ-UHFFFAOYSA-N nepetin Chemical compound C=1C(=O)C2=C(O)C(OC)=C(O)C=C2OC=1C1=CC=C(O)C(O)=C1 FHHSEFRSDKWJKJ-UHFFFAOYSA-N 0.000 description 2
- 229940053128 nerve growth factor Drugs 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 230000000541 pulsatile effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000002438 upper gastrointestinal tract Anatomy 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- 235000012035 Boswellia serrata Nutrition 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 229920003163 Eudragit® NE 30 D Polymers 0.000 description 1
- 229920003141 Eudragit® S 100 Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 241000736262 Microbiota Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Natural products OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000010398 acute inflammatory response Effects 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 241000902900 cellular organisms Species 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229940102465 ginger root Drugs 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 235000004280 healthy diet Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000008102 immune modulation Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 229940076144 interleukin-10 Drugs 0.000 description 1
- 229940117681 interleukin-12 Drugs 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007269 microbial metabolism Effects 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000021315 omega 9 monounsaturated fatty acids Nutrition 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 230000000065 osmolyte Effects 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000004983 pleiotropic effect Effects 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229940109529 pomegranate extract Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
- A23K50/42—Dry feed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
- A23K50/45—Semi-moist feed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/502—Gums
- A23V2250/5044—Flax seed
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Abstract
Description
例示的なペットフード組成物(実施例1)は、(下記)表2に記載されるように調製される。全ての量を、ペットフード組成物の総重量に基づいて、重量パーセントで示す。この組成物は、アメリカ飼料検査官協会(AAFCO)及び米国学術研究会議(NRC)によって規定される栄養基準に従って配合される。この組成物は、押出成形で製造され、乾燥され、次いで美味剤でコーティングされる。
* PA 2 = パルミトイル-アラキドノイル-グリセロホスホコリン (2)
* PA 3 = ステアロイル-アラキドノイル-グリセロホスホコリン (2)
* PA 4 = ステアロイル-アラキドノイル-グリセロホスホエタノールアミン (1)
* PA 5 = ステアロイル-アラキドノイル-グリセロホスホイノシトール (2)
第2の例示的なペットフード組成物の免疫最適化を決定するために、給餌試験を実施する。例示的なペットフード組成物(実施例2)は、下記の表8に記載されるように調製される。全ての量を、ペットフード組成物の総重量に基づいて、重量パーセントで示す。この組成物は、アメリカ飼料検査官協会(AAFCO)及び米国学術研究会議(NRC)によって規定される栄養基準に従って配合される。この組成物は、押出成形で製造され、乾燥され、次いで美味剤でコーティングされる。(下記)表8に記載される組成物を製造するのに使用される方法は、本発明の基材の生成を確実にする。
イヌに、対照食餌又は実施例2からなる食餌を、クロスオーバー試験(cross-over design)にて6週間与える。被検体は、本発明の例示的な組成物(実施例2)を摂取する前の3週間、維持食餌(maintenance diet;Hill’s Pet Nutrition、Inc.より市販のHill’s(登録商標)Science Diet(登録商標)Canine Adult)を摂取する予備給餌期(pre-feed phase)に参加した。ベースライン測定は、予備給餌期の終了時に実施される。対照食餌は、より低濃度の繊維結合ポリフェノール栄養源及び総繊維含量を含有し、繊維は主に不溶性形態である。
イヌに、対照食餌又は実施例3からなる食餌を、クロスオーバーなしで13週間連続して摂取させる。予備給餌期間はなかった。対照食餌は、試験食餌より低い濃度の繊維結合ポリフェノール栄養源を含有し、総繊維含有量が一致するが、繊維は主に不溶性の形態であった。
微生物由来のポストバイオティクスの血清濃度について、本発明の放出制御基材を含む本発明の例示的な組成物(実施例3)を与えたイヌ、及び本発明の放出制御基材を含む比較組成物を与えたイヌにて評価する。比較組成物及び実施例3を13週間与えられたイヌの血清サンプルの微生物ポリフェノール代謝産物及びそれらの第II相解毒共役体の濃度の違いについて分析する。ポリフェノールの(非)共役微生物代謝産物の相対血清濃度について、経路濃縮分析を行う。結果は、次のことを示す。すなわち、特定の食餌成分の細菌代謝産物は、比較組成物を与えられたイヌにおけるよりも、実施例3を与えられたイヌの血清において、より顕著に現れることを示している。これらの結果は、有益な薬剤、例えばポリフェノールの標的指向送達を提供する本発明の組成物の能力を更に示す。
Claims (21)
- 高溶解性繊維源および低溶解性繊維源を含む繊維成分と、
ポリフェノール源とを含む基材を含む、放出制御ペットフード組成物であって、
前記基材は、哺乳動物による摂取後に、前記ポリフェノール源を哺乳動物の下部消化器(GI)管に送達するように構成される、放出制御ペットフード組成物。 - 高溶解性繊維源についての低溶解性繊維源に対する重量比は、約1:20〜約1:1である、請求項1に記載のペットフード組成物。
- 高溶解性繊維源についての低溶解性繊維源に対する重量比は、約1:15〜約1:2である、請求項1又は請求項2に記載のペットフード組成物。
- 高溶解性繊維源についての低溶解性繊維源に対する重量比は、約1:10〜約1:3である、請求項1〜3のいずれかに記載のペットフード組成物。
- 高溶解性繊維源についての低溶解性繊維源に対する重量比は、約1:5〜約1:3である、請求項1〜4のいずれかに記載のペットフード組成物。
- 高溶解性繊維源についての低溶解性繊維源に対する重量比は、約1:4である、請求項1〜5のいずれかに記載のペットフード組成物。
- 前記高溶解性繊維源は、オート麦ふすま、ソバ挽き割り、エンドウ豆ふすま、大麦、トマトかす、柑橘類パルプ、ビートパルプ、及びそれらの2つ以上の組み合わせを含む、請求項1〜6のいずれかに記載のペットフード組成物。
- 前記低溶解性繊維源は、セルロース系材料、ピーカン繊維、又はそれらの組み合わせを含む、請求項1〜7のいずれかに記載のペットフード組成物。
- 前記ポリフェノール源は、食品又は植物由来である、請求項1〜8のいずれかに記載のペットフード組成物。
- 食品由来の前記ポリフェノール源は、果物又は野菜由来のポリフェノールを含む、請求項9に記載のペットフード組成物。
- 前記ポリフェノール源は、フラボノイド又はフェノール酸を含む、請求項1〜10のいずれかに記載のペットフード組成物。
- 前記ポリフェノール源は、デヒドロキシロスマリン酸、クマロイルネピトリン、ユーパフォリン、カルノソール、スクテラリン、ケンフェロール、ロスマリン酸、ロスマノール、シルシマリチン、ルテオリン、6−メトキシ−ルテオリン、7−エピロスマンノール、ケルセチン、カテキン、ヘスペリジン、シアニジン、及びこれらの2つ以上の組み合わせから選択されるポリフェノールを提供する、請求項1〜11のいずれかに記載のペットフード組成物。
- アミノ酸プロファイルを含む加水分解された動物性又は植物性タンパク質の供給源を更に含む、請求項1〜12のいずれかに記載のペットフード組成物。
- 加水分解された動物性又は植物性タンパク質の前記供給源は、鶏の肝臓を含む、請求項13に記載のペットフード組成物。
- 加水分解された動物性又は植物性タンパク質の前記供給源は、約25〜約45重量%の活性含有量で存在する、請求項13又は請求項14に記載のペットフード組成物。
- 高ドコサヘキサエン酸魚油を更に含む、請求項1〜15のいずれかに記載のペットフード組成物。
- 前記高ドコサヘキサエン酸魚油の前記活性含有量は、約0.5〜約2.5重量%である、請求項16に記載のペットフード組成物。
- 炎症性の疾患、状態若しくは障害の症状について、例えば哺乳動物の炎症性腸疾患について治療、予防、又は改善する方法であって、請求項1〜17のいずれかに記載の組成物の有効量を、それを必要とする哺乳動物に投与することを含む、方法。
- 哺乳動物の腸内ミクロフローラを有益に操作する方法であって、請求項1〜17のいずれか一項に記載の組成物の有効量を、それを必要とする哺乳動物に投与することを含む、方法。
- ペットフード組成物を形成する方法であって、
基材を押し出す工程であって、前記基材が、
高溶解性繊維源及び低溶解性繊維源を含む繊維成分と、
ポリフェノール源と、を含むものである、押し出す工程と、
キブルに表面コーティングを施す工程と、を含み、
前記基材は、前記ポリフェノール源を、哺乳動物によって摂取された後に前記哺乳動物の下部消化器(GI)管へ送達するように構成される、方法。 - 前記表面コーティングは美味剤を含む、請求項20に記載の方法。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2015/068193 WO2017116449A1 (en) | 2015-12-30 | 2015-12-30 | Pet food compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019500048A true JP2019500048A (ja) | 2019-01-10 |
JP6821683B2 JP6821683B2 (ja) | 2021-01-27 |
Family
ID=55168469
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018534734A Active JP6821683B2 (ja) | 2015-12-30 | 2015-12-30 | ペットフード組成物 |
JP2018534695A Active JP6821682B2 (ja) | 2015-12-30 | 2016-12-27 | ペットフード組成物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018534695A Active JP6821682B2 (ja) | 2015-12-30 | 2016-12-27 | ペットフード組成物 |
Country Status (10)
Country | Link |
---|---|
US (3) | US20190014796A1 (ja) |
EP (2) | EP3397068B1 (ja) |
JP (2) | JP6821683B2 (ja) |
CN (2) | CN108430230A (ja) |
AU (2) | AU2015419243B2 (ja) |
BR (2) | BR112018012966B1 (ja) |
CA (2) | CA3008616A1 (ja) |
MX (2) | MX2018007862A (ja) |
RU (2) | RU2706953C1 (ja) |
WO (2) | WO2017116449A1 (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3081756A1 (en) * | 2017-11-17 | 2019-05-23 | Hill's Pet Nutrition, Inc. | Compositions comprising omega-3 polyunsaturated and medium chain fatty acids |
EP3639674A1 (en) * | 2018-10-18 | 2020-04-22 | Mars, Incorporated | Pet food compositions for weight management in pets with adverse food reaction |
US20210227852A1 (en) * | 2018-12-17 | 2021-07-29 | Hill's Pet Nutrition, Inc. | Pet food compositions |
AU2018453930B2 (en) * | 2018-12-20 | 2022-09-29 | Hill's Pet Nutrition, Inc. | Pet food compositions |
US20220117265A1 (en) * | 2019-01-18 | 2022-04-21 | Mars, Incorporated | Methods and compositions for treating intestinal dysbiosis |
MX2022000295A (es) * | 2019-07-09 | 2022-02-03 | Hills Pet Nutrition Inc | Composiciones alimenticias para mascotas. |
GB201914385D0 (en) * | 2019-10-04 | 2019-11-20 | Mars Inc | Microbiome Interventions |
US20220395001A1 (en) * | 2019-12-27 | 2022-12-15 | Hill's Pet Nutrition, Inc. | Pet Food Compositions |
CA3176760A1 (en) * | 2020-04-06 | 2021-10-14 | Hill's Pet Nutrition, Inc. | Pet food compositions |
KR102497918B1 (ko) * | 2020-10-16 | 2023-02-09 | (주)에이티바이오 | 발효취가 완화된 반려동물용 발효사료 및 그의 제조방법 |
US20240058290A1 (en) * | 2020-12-22 | 2024-02-22 | Hill's Pet Nutrition, Inc. | Pet Food Compositions |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007512342A (ja) * | 2003-11-21 | 2007-05-17 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 組成物及び方法 |
JP2008535520A (ja) * | 2005-04-11 | 2008-09-04 | ザ・アイムス・カンパニー | プロバイオティクス構成成分及び甘味剤構成成分を含む組成物 |
JP2015507629A (ja) * | 2011-12-29 | 2015-03-12 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 消化管フローラを改良する組成物および方法 |
JP2015521052A (ja) * | 2012-06-07 | 2015-07-27 | フラヴィトピュア インコーポレイテッド | 動物飼料におけるカラマツの木材抽出物を利用する方法及び組成物 |
WO2015146853A1 (ja) * | 2014-03-24 | 2015-10-01 | 株式会社ダイセル | 栄養組成物 |
JP2018534695A (ja) * | 2015-11-11 | 2018-11-22 | クアルコム,インコーポレイテッド | 仮想マシンまたはエミュレータのプログラム回避検出 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6156355A (en) * | 1998-11-02 | 2000-12-05 | Star-Kist Foods, Inc. | Breed-specific canine food formulations |
JP5342231B2 (ja) * | 2005-05-13 | 2013-11-13 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 増強された食味を有するドライフード組成物 |
CN101351124B (zh) * | 2005-12-29 | 2014-09-03 | 希尔氏宠物营养品公司 | 用于改变动物的肠道菌群的方法 |
US8691303B2 (en) * | 2009-07-31 | 2014-04-08 | The Iams Company | Dusted animal food |
US8691792B2 (en) * | 2009-08-05 | 2014-04-08 | Nestec Sa | Methods and compositions for improving gastrointetinal health |
WO2011090676A1 (en) * | 2009-12-29 | 2011-07-28 | Hill's Pet Nutrition, Inc. | Compositions including pyruvate for companion animals and methods of use thereof |
CN105558385A (zh) * | 2010-08-03 | 2016-05-11 | 希尔氏宠物营养品公司 | 具有抗微生物活性的宠物食品组合物 |
PL2731449T3 (pl) * | 2011-07-12 | 2015-04-30 | Specialites Pet Food | Środki poprawiające smakowitość, które zawierają wolne aminokwasy, do stosowania w karmie dla zwierząt domowych |
CN103461730A (zh) * | 2013-09-29 | 2013-12-25 | 江南大学 | 一种改善犬抗氧化能力和肠道健康状况的犬粮及其制备方法 |
KR102004457B1 (ko) * | 2015-11-30 | 2019-07-29 | 주식회사 엘지화학 | 이차전지용 양극활물질 및 이를 포함하는 이차전지 |
-
2015
- 2015-12-30 BR BR112018012966-6A patent/BR112018012966B1/pt active IP Right Grant
- 2015-12-30 JP JP2018534734A patent/JP6821683B2/ja active Active
- 2015-12-30 EP EP15825764.2A patent/EP3397068B1/en active Active
- 2015-12-30 AU AU2015419243A patent/AU2015419243B2/en active Active
- 2015-12-30 CN CN201580085631.0A patent/CN108430230A/zh active Pending
- 2015-12-30 RU RU2018123800A patent/RU2706953C1/ru active
- 2015-12-30 US US16/067,238 patent/US20190014796A1/en active Pending
- 2015-12-30 WO PCT/US2015/068193 patent/WO2017116449A1/en active Application Filing
- 2015-12-30 CA CA3008616A patent/CA3008616A1/en active Pending
- 2015-12-30 MX MX2018007862A patent/MX2018007862A/es unknown
-
2016
- 2016-12-27 CN CN201680076935.5A patent/CN108471783A/zh active Pending
- 2016-12-27 JP JP2018534695A patent/JP6821682B2/ja active Active
- 2016-12-27 RU RU2018123803A patent/RU2740439C2/ru active
- 2016-12-27 CA CA3009191A patent/CA3009191A1/en active Pending
- 2016-12-27 US US16/067,426 patent/US20190008186A1/en not_active Abandoned
- 2016-12-27 BR BR112018013011-7A patent/BR112018013011B1/pt active IP Right Grant
- 2016-12-27 AU AU2016381433A patent/AU2016381433B2/en active Active
- 2016-12-27 WO PCT/US2016/068644 patent/WO2017117091A1/en active Application Filing
- 2016-12-27 MX MX2018007991A patent/MX2018007991A/es unknown
- 2016-12-27 EP EP16825682.4A patent/EP3397069A1/en active Pending
-
2022
- 2022-10-27 US US17/975,528 patent/US20230067342A1/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007512342A (ja) * | 2003-11-21 | 2007-05-17 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 組成物及び方法 |
JP2008535520A (ja) * | 2005-04-11 | 2008-09-04 | ザ・アイムス・カンパニー | プロバイオティクス構成成分及び甘味剤構成成分を含む組成物 |
JP2015507629A (ja) * | 2011-12-29 | 2015-03-12 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 消化管フローラを改良する組成物および方法 |
JP2015521052A (ja) * | 2012-06-07 | 2015-07-27 | フラヴィトピュア インコーポレイテッド | 動物飼料におけるカラマツの木材抽出物を利用する方法及び組成物 |
WO2015146853A1 (ja) * | 2014-03-24 | 2015-10-01 | 株式会社ダイセル | 栄養組成物 |
JP2018534695A (ja) * | 2015-11-11 | 2018-11-22 | クアルコム,インコーポレイテッド | 仮想マシンまたはエミュレータのプログラム回避検出 |
Also Published As
Publication number | Publication date |
---|---|
AU2015419243B2 (en) | 2019-02-14 |
CN108471783A (zh) | 2018-08-31 |
EP3397068B1 (en) | 2022-09-14 |
MX2018007862A (es) | 2018-09-06 |
RU2018123803A (ru) | 2019-12-30 |
BR112018012966B1 (pt) | 2022-07-12 |
BR112018012966A2 (pt) | 2018-12-04 |
AU2016381433A1 (en) | 2018-06-28 |
EP3397068A1 (en) | 2018-11-07 |
CN108430230A (zh) | 2018-08-21 |
EP3397069A1 (en) | 2018-11-07 |
MX2018007991A (es) | 2018-11-09 |
US20190014796A1 (en) | 2019-01-17 |
BR112018013011A2 (pt) | 2018-12-04 |
RU2740439C2 (ru) | 2021-01-14 |
JP6821683B2 (ja) | 2021-01-27 |
JP6821682B2 (ja) | 2021-01-27 |
RU2018123803A3 (ja) | 2020-04-08 |
CA3008616A1 (en) | 2017-07-06 |
AU2015419243A1 (en) | 2018-06-28 |
JP2019500047A (ja) | 2019-01-10 |
US20230067342A1 (en) | 2023-03-02 |
CA3009191A1 (en) | 2017-07-06 |
AU2016381433B2 (en) | 2019-02-14 |
US20190008186A1 (en) | 2019-01-10 |
WO2017116449A1 (en) | 2017-07-06 |
BR112018013011B1 (pt) | 2022-10-11 |
WO2017117091A1 (en) | 2017-07-06 |
RU2706953C1 (ru) | 2019-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6821682B2 (ja) | ペットフード組成物 | |
DE60212964T2 (de) | Zusammensetzungen zur behandlung von tierischen krankheiten und syndromen mit transferfaktor | |
Peixoto et al. | Effect of resistant starch on the intestinal health of old dogs: fermentation products and histological features of the intestinal mucosa | |
KR101559515B1 (ko) | 기능성 사료 첨가제 조성물 | |
JP2016513966A (ja) | サーチュイン活性化剤によるペットの処置 | |
CN105431159B (zh) | 关节护理组合物 | |
US11930831B2 (en) | Composition and method for reducing or treating oral inflammation | |
Adedokun et al. | The response in jejunal and ileal nutrient and energy digestibility and the expression of markers of intestinal inflammation in broiler chickens to coccidial vaccine challenge and phytase supplementation | |
El‐Deep et al. | In ovo injection of nano‐selenium spheres mitigates the hatchability, histopathology image and immune response of hatched chicks | |
Yusuf et al. | Influence of turmeric (Curcuma longa) on performance, histomorphology and microbiota of intestine in juvenile tilapia (Oreochromis niloticus) | |
Lin et al. | Effect of initial time of forage supply on growth and rumen development in preweaning calves | |
Kilburn-Kappeler et al. | Evaluation of a yeast β-glucan blend in a pet food application to determine its impact on stool quality, apparent nutrient digestibility, and intestinal health when fed to dogs | |
Saraswati et al. | Physiological condition of first female and male offspring of Japanese quail (Coturnix japonica) whose parents were supplemented by turmeric powder | |
Eissa et al. | Dietary Effects of Nano Curcumin on Growth Performances, Body Composition, Blood Parameters and Histopathological Alternation in Red Tilapia (Oreochromis sp.) Challenged with Aspergillus flavus. Fishes 2023, 8, 208 | |
TW202114707A (zh) | 動物食物組合物 | |
RU2784353C2 (ru) | Питательная смесь для достижения полезных для здоровья эффектов у животных | |
Maneewan et al. | Effects of dietary C entella asiatica (L.) U rban on growth performance, nutrient digestibility, blood composition in piglets vaccinated with M ycoplasma hyopneumoniae | |
Abousekken et al. | EFFECT OF SLIVER NANOPARTICLES WITH COTULA CINERIA EXTRACT ON GROWING RABBITS PERFORMANCE, DIGESTIBILITY AND CARCASS QUALITY | |
Bano et al. | Enhancing farmed striped catfish (Pangasianodon hypophthalmus) robustness using dietary β-glucan | |
Almeida et al. | Conditioned aversion induced by Baccharis coridifolia in sheep and cattle. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180726 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180726 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20190121 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190412 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20190530 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20190530 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A132 Effective date: 20190702 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191002 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200407 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200707 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20201208 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210106 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6821683 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |